ReviewFrontiers in immunology2024
IL-2 based cancer immunotherapies: an evolving paradigm.
Sushama Rokade et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled itcites it
ReviewFrontiers in immunology2024
Sushama Rokade et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.